Differences in metallothionein expression in transplantable mouse mammary tumor lines

Cancer Letters

Volumn 138, Issue 1-2, 1999, Pages 167-174

  Yamamura, Yuichi ^a   Sayama, Kazutoshi ^b   Takeda, Yasutaka ^c   Matsuzawa, Akio ^c   Iguchi, Taisen ^d   Ohta, Yasuhiko ^e  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b SHIZUOKA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

^e TOTTORI UNIVERSITY   (Japan)

Author keywords

Estrogen receptor; Metallothionein; Mouse; Progesterone receptor; Transplantable mammary tumor

Indexed keywords

ESTROGEN RECEPTOR; METALLOTHIONEIN; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST TUMOR; CANCER GRAFT; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; FEMALE; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, EXPERIMENTAL; METALLOTHIONEIN; MICE; MITOSIS; NEOPLASM TRANSPLANTATION; PREGNANCY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR CELLS, CULTURED;

EID: 0033606135     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00002-6     Document Type: Article

References (36)

1. Andrews G.K., Murphy M.P., Howell S.B. Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cells. Cancer Chemother. Pharmacol. 19:1987;149-154.
2. Bier B., Douglas-Jones A.G., Totsch M., Dockhorn-Dworniczak B., Boker W., Jasani B., Schmid K.W. Immunohistochemical demonstration of metallothionein in normal human breast tissue and malignant breast lesions. Breast Cancer Res. Treat. 30:1994;213-221.
3. Cherian M.G. Nuclear and cytoplasmic localization of metallothionein in human liver during development and in tumor cells. Suzuki K.T., Kimura M. Metallothionein III. 1993;175-187 Birkhäuser Verlag, Basel.
4. Cherian M.G., Howell S.B., Imura N., Klaassen C.D., Koropatnick J., Lazo J.S., Waalkes M.P. Role of metallothionein in carcinogenesis. Toxicol. Appl. Pharmacol. 126:1994;1-5.
5. Douglas-Jones A.G., Frepa K.W., Schmid K.W., Bier B., Horgan K., Lyons K., Dallimore N.D., Moneypenny I.J. Metallothionein expression in duct carcinoma in situ of the breast. Hum. Pathol. 26:1995;217-222.
6. Dunn T.B. Morphology of mammary tumors in mice. Homburger F. Physiopathology of Cancer. 1959;38-84 Hoeber, New York.
7. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82:1959;70-77.
8. Fresno M., Wu W., Rodrigues J.M. Localization of metallothionein in breast carcinomas. An immunohistochemical study. Virchows Arch. A. 43:1993;215-219.
9. Goulding H., Jasani B., Pereira H., Reid A., Galea M., Bell J.A., Elston C.W., Robertson J.F., Blamey R.W., Nicholson R.A., Schimd K.W., Ellis I.O. Metallothionein expression in human breast cancer. Br. J. Cancer. 72:1995;968-972.
10. Haerslev T., Jacobsen K., Nedergaard L., Zedeler K. Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastasis. Pathol. Res. Pract. 190:1994;675-681.
11. Hamer D.E. Metallothionein. Annu. Rev. Biochem. 55:1986;913-951.
12. 3 in cultured cells and mice. Proc. Natl. Acad. Sci. USA. 84:1987;8810-8814.
13. Kelley S.L., Basu T., Teicher B.A. Overexpression of metallothionein confers resistance to anticancer drugs. Science. 241:1988;1813-1815.
14. Kontozoglou T.E., Banerjee D., Cherian G. Immunohistochemical localization of metallothionein in human testicular embryonal carcinoma cells. Virchows Arch. A. 415:1987;545-549.
15. Kontozoglou T.E., Banerjee D., Cherian M. Immunohistochemical localization of metallothionein in human testicular embryonal carcinoma cells. Virchows Arch. A. 415:1989;545-549.
16. Kägi J.H. Overview of metallothionein. Methods Enzymol. 205:1991;613-626.
17. Liotta L.A., Steeg P.S., Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 64:1991;327-336.
18. Matsuzawa A. Hormone dependence and independence of mammary tumors in mice. Int. Rev. Cytol. 103:1986;303-340.
19. Matsuzawa A., Kaneko T., Ikeda Y. Accelerated progression to autonomy of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by hormones. Cancer Res. 43:1983;2283-2289.
20. Matsuzawa A., Yamamoto T. A transplantable pregnancy-dependent mammary tumor line (TPDMT-4) in strain DDD mice. Jpn. J. Cancer Res. 65:1974;306-315.
21. Murakami A., Tanaka H., Matsuzawa A. Association of hst expression with metastatic potential in mouse mammary tumors. Cell Growth Diff. 1:1990;225-231.
22. Murphy G., Reynolds J.J., Hembry R.M. Metalloproteinases in cancer invasion and metastases. Int. J. Cancer. 44:1989;757-760.
23. Nakashima K., Akimoto H., Nishida K. High-performance liquid chromatography-fluorometry for the determination of thiols in biological samples using N-[4-(6-dimethylamino-2-benzofuranyl)phenyl]-maleimide. J. Chromatogr. 414:1987;11-17.
24. Oyama T., Takei H., Hikino Y., Iino Y., Nakajima T. Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology and prognosis. Oncology. 53:1996;112-117.
25. Reid A., Pereira H., Galea M., Bell J.A., Elston C.W., Jasani B., Schimid K.W., Kay J., Cryer A. Metallothionein in human breast cancer. J. Pathol. Suppl. 167:1992;29A.
26. Schmid K.W., Ellis I.O., Gee J.N.W., Darke B.M., Lees W.E., Kay J., Cryer J., Stark J.M., Hittmair A., Öfner D., Dünser M., Margreiter R., Daxenbichler G., Nicholson R.I., Bier B., Böcker W., Jasani B. Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of breast. Virchows Arch. A. 422:1993;153-159.
27. Shinogi M., Nishinaga K., Yokoyama I. Measurement of metallothionein in rat tissues by a chromatographic method using the fluorometry of thiol groups. Biol. Pharm. Bull. 19:1996;911-914.
28. Slater E.P., Cato A.C.B., Karin M., Baxter J.D. Progesterone induction of metallothionein-IIA gene expression. Mol. Endocrinol. 2:1988;485-491.
29. Straus W. Imidazole increases the sensitivity of the cytochemical reaction for peroxidase with diaminobenzidine at a neutral pH. J. Histochem. Cytochem. 30:1982;491-493.
30. Takeda Y., Matsuzawa A., Kaneko T., Sekiguchi M., Fujii G. Effects of repeated exposure to cyclophosphamide on drug resistance and biological properties of a newly autonomy-acquired mouse mammary tumor (T4-OI320). Jpn. J. Exp. Med. 58:1988;87-98.
31. Takeda Y., Sayama K., Saegusa Y., Matuzawa A. Progression toward metastatic phenotype with loss of Growth-inhibiting tumor-cell/cell interactions in vitro. Int. J. Cancer. 62:1995;579-584.
32. Udom A.O., Brady F.O. Reactivation in vitro of zinc-requiring apo-enzymes by rat liver zinc-thionein. Biochem. J. 187:1980;329-335.
33. Webber M.M., Regman S.M.M., James G.T. Metallothionein induction and deinduction in human prostatic carcinoma cells: relationship with resistance and sensitivity to adriamycin. Cancer Res. 48:1988;4503-4508.
34. Yamaguchi R., Kurasaki M., Kojima Y. A mutant metallothionein which has inverse fragment composition exhibits high cadmium-binding ability. Biochem. Mol. Biol. Int. 41:1997;49-56.
35. Zelger B., Hittmair A., Schir M., Öfner C., Öfner D., Fritsch P., Böcker W., Jasani B., Schmid K.W. Immunohistochemically demonstrated metallothionein expression in malignant melanoma. Histopathology. 23:1993;257-264.
36. Zelger B., Schir M., Hittmair A., Öfner C., Fritsch P., Jasani B., Schmid K.W. Metallothionein over-expression in malignant melanoma - a factor of prognostic value? Cut. Pathol. 18:1991;398.